Skip to main content
. 2018 Sep 9;2018:2047242. doi: 10.1155/2018/2047242

Figure 3.

Figure 3

Cumulative hazard for escalation of medical therapy in response to uncontrolled IBD between patients receiving or not receiving SSRIs.